MIGUEL S. BENET - 21 Feb 2025 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Signature
Christopher G. Cobb, Attorney in Fact for Miguel S. Benet
Issuer symbol
CYH
Transactions as of
21 Feb 2025
Net transactions value
-$84,159
Form type
4
Filing time
25 Feb 2025, 16:16:47 UTC
Previous filing
02 Jan 2025
Next filing
03 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Sale $84,159 -23,875 -30% $3.52 55,000 21 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYH Performance Based Restricted 15,000 21 Feb 2025 Common Stock 15,000 $0.000000 Direct F2
holding CYH Performance Based Restricted 30,000 21 Feb 2025 Common Stock 30,000 $0.000000 Direct F3
holding CYH Performance Based Restricted 30,000 21 Feb 2025 Common Stock 30,000 $0.000000 Direct F4
holding CYH Stock Options (Right to Buy) 15,000 21 Feb 2025 Common Stock 15,000 $10.18 Direct F5
holding CYH Stock Options (Right to Buy) 30,000 21 Feb 2025 Common Stock 30,000 $6.15 Direct F5
holding CYH Stock Options (Right to Buy) 30,000 21 Feb 2025 Common Stock 30,000 $2.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold in a series of transactions at a sales price of $3.525 per share.
F2 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
F3 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
F4 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F5 Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.